E · P · C
Bio Reactor : 500 ℓ
The Chungju plant of Reyon Pharmaceutical is a pharmaceutical complex that produces state-of-the-art gene therapy products and synthetic drugs. We were awarded this project in an e (re-engineering), P, C + Validation format. This project was our first gene therapy medicine production facility project. Gene therapy product is the third-generation biomedicine following the second-generation biomedicine, the anti-body treatment medicine. The project signals our entry into the next-generation market that holds great growth potentials. We have secured a global competitive edge from building various second-generation biomedicine production facilities, such as Samsung Biologics Phase 1~3 Plants and Dong-A DM Bio Project. With Reyon Pharm Evergreen Project, we are committed to becomimg a leading company in the fast-growing cell and gene therapy medicine plant market.
We refuse the unauthorized collection of email addresses posted on this website using an email address collection program or other technical systems. Please be informed that if violated, criminal charges will be filed pursuant to the Act on Promotion of Information and Communications Network Utilization and Information Protection.